MX9909548A - Metodos para la reduccion de fibrinogenos. - Google Patents

Metodos para la reduccion de fibrinogenos.

Info

Publication number
MX9909548A
MX9909548A MXPA99009548A MX9909548A MX9909548A MX 9909548 A MX9909548 A MX 9909548A MX PA99009548 A MXPA99009548 A MX PA99009548A MX 9909548 A MX9909548 A MX 9909548A MX 9909548 A MX9909548 A MX 9909548A
Authority
MX
Mexico
Prior art keywords
methods
reducing fibrinogen
fibrinogen
reducing
arylbenzo
Prior art date
Application number
MXPA99009548A
Other languages
English (en)
Other versions
MXPA99009548A (es
Inventor
Wang Anderson Pamela
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9909548A publication Critical patent/MX9909548A/es
Publication of MXPA99009548A publication Critical patent/MXPA99009548A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

La invencion se refiere a reduccion de fibrinogeno en un humano administrando un compuesto 2-aroil-3-arilbenzo[b]tiofeno.
MXPA/A/1999/009548A 1997-04-22 1999-10-18 Metodos para la reduccion de fibrinogenos MXPA99009548A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22
US60/044,591 1997-04-22
PCT/US1998/007862 WO1998047365A1 (en) 1997-04-22 1998-04-20 Methods for reducing fibrinogen

Publications (2)

Publication Number Publication Date
MX9909548A true MX9909548A (es) 2003-02-27
MXPA99009548A MXPA99009548A (es) 2003-10-20

Family

ID=

Also Published As

Publication number Publication date
NO995132D0 (no) 1999-10-21
DK0878195T3 (da) 2002-07-15
EP0878195B1 (en) 2002-06-19
PT878195E (pt) 2002-09-30
NZ500389A (en) 2001-07-27
ID22910A (id) 1999-12-16
JP2001524101A (ja) 2001-11-27
WO1998047365A1 (en) 1998-10-29
AU741720B2 (en) 2001-12-06
AU7250398A (en) 1998-11-13
CA2287196A1 (en) 1998-10-29
DE69806098D1 (de) 2002-07-25
CN1254255A (zh) 2000-05-24
ATE219364T1 (de) 2002-07-15
US6025373A (en) 2000-02-15
PL336638A1 (en) 2000-07-03
KR20010012084A (ko) 2001-02-15
NO995132L (no) 1999-10-21
EA199900959A1 (ru) 2000-06-26
TR199902605T2 (xx) 2000-02-21
ES2178111T3 (es) 2002-12-16
HUP0002727A3 (en) 2001-09-28
EP0878195A1 (en) 1998-11-18
BR9809286A (pt) 2000-07-04
HUP0002727A2 (hu) 2001-08-28
EA002237B1 (ru) 2002-02-28
ZA983298B (en) 1999-10-20
IL132504A0 (en) 2001-03-19
DE69806098T2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
HN1997000012A (es) Derivados de triazol utiles en terapia.
GB9310163D0 (en) Improvements relating to injection devices
BG101540A (en) Interferon conjugates
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
GB9907461D0 (en) Neurite regeneration
MY107158A (en) 3-arylcarbonyl; -1h-indoles useful as therapeutic agents.
GB9808408D0 (en) Improvements relating to injection devices
GB9803084D0 (en) Improvements relating to medical injection devices
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
GB9418122D0 (en) Improvements relating to injection devices
EP0776229A4 (en) SHOWER END
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
BG103096A (en) Thrombin inhibitors
DE59800935D1 (en) Immuntolerante prothrombinkomplex-präparation
MX9704050A (es) P-amidinobencilamidas de dipeptido novedosas con radicales sulfonilo o aminosulfonilo en terminal n.
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
PH30818A (en) Novel substituted thienopyrans as antihpertensive agents.
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
MX9909548A (es) Metodos para la reduccion de fibrinogenos.
ATE90195T1 (de) Minoxidil-gel.
HN1997000013A (es) Compuestos 1,4 dihidropiridina
AU3610999A (en) Thiocolchicoside derivative, preparation and therapeutic application
GB2331705B (en) Tool for administering injections to livestock
GB8820337D0 (en) Improvements relating to cytotoxin
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці